Kiniksa Pharmaceuticals Ltd Net Asset Quality Index
Kiniksa Pharmaceuticals Ltd net asset quality index. Kiniksa Pharmaceuticals Ltd (KNSA) has a Net Asset Quality Index of 73.0% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $896.11 Million minus total liabilities of $241.96 Million yields net assets of $654.15 Million. A higher index indicates a stronger, lower-leverage balance sheet. See KNSA net asset value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Kiniksa Pharmaceuticals Ltd (2016–2025)
Net asset quality index of Kiniksa Pharmaceuticals Ltd from 2016 to 2025. This chart shows how Kiniksa Pharmaceuticals Ltd's Net Asset Quality Index has evolved across 10 annual periods from 2016 to 2025. As of June 2026, the index stands at 73.0%, representing net assets of $654.15 Million against total assets of $896.11 Million USD. Check how strategically is Kiniksa Pharmaceuticals Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.
Kiniksa Pharmaceuticals Ltd Net Asset Quality Index by Year (2016–2025)
Kiniksa Pharmaceuticals Ltd net asset quality index by year from 2016 to 2025. The table below presents the year-by-year Net Asset Quality Index for Kiniksa Pharmaceuticals Ltd from 2016 to 2025, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Kiniksa Pharmaceuticals Ltd.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 74.3% | $567.61 Million | $763.63 Million | $196.03 Million | ▼ -1.2 pp |
| 2024 | 75.5% | $438.44 Million | $580.55 Million | $142.12 Million | ▼ -7.9 pp |
| 2023 | 83.4% | $438.84 Million | $526.32 Million | $87.48 Million | ▼ -2.8 pp |
| 2022 | 86.2% | $396.15 Million | $459.67 Million | $63.52 Million | ▲ +6.7 pp |
| 2021 | 79.5% | $185.04 Million | $232.80 Million | $47.76 Million | ▼ -9.8 pp |
| 2020 | 89.3% | $311.94 Million | $349.46 Million | $37.53 Million | ▲ +0.7 pp |
| 2019 | 88.6% | $225.42 Million | $254.53 Million | $29.11 Million | ▲ +1.8 pp |
| 2018 | 86.7% | $279.27 Million | $321.96 Million | $42.70 Million | ▲ +275.6 pp |
| 2017 | -188.9% | $-89.71 Million | $47.49 Million | $137.20 Million | ▼ -143.3 pp |
| 2016 | -45.6% | $-25.73 Million | $56.47 Million | $82.20 Million | — |